After hours: 4:30PM EDT
|Bid||73.34 x 800|
|Ask||74.75 x 900|
|Day's Range||72.38 - 73.62|
|52 Week Range||57.41 - 74.14|
|Beta (3Y Monthly)||0.86|
|PE Ratio (TTM)||27.44|
|Earnings Date||Jul 25, 2019 - Jul 29, 2019|
|Forward Dividend & Yield||1.72 (2.36%)|
|1y Target Est||70.53|
While Colgate-Palmolive (CL) has beaten Wall Street’s EPS expectations in the past two quarters, its adjusted EPS have fallen in the past three quarters.
Whereas Colgate-Palmolive’s (CL) top line beat analysts' estimate in the first quarter, it has missed their estimates in four of the past five quarters.
Colgate-Palmolive (CL) stock has gained substantially this year, outperforming broader markets. The stock has risen 23.3%, while the S&P 500 has risen 15.3%. Let's look at what's boosted the stock.
Procter & Gamble (PG) emphasizes on improving its product portfolio through strategic initiatives. Also, the company is on track with its cost-saving plans.
Colgate-Palmolive Co NYSE:CLView full report here! Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for CL with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CL. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding CL are favorable, with net inflows of $10.35 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. CL credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Church & Dwight's (CHD) top line has been impressive for a while, gaining from strong Consumer International unit, buyouts and innovation.
Newell's (NWL) dismal sales surprise trend can be attributed to lower core sales and adverse foreign currency. Nevertheless, its Transformation Plan appears encouraging.
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Colgate-Palmolive Company and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
Huawei Strikes Back…Against Verizon Chinese Telecom Huawei, pretty upset about President Trump’s sanctions against the company that have led to Alphabet (NASDAQ:GOOGL) banning the company from using its Android operating system for its phones among other things, is striking back by insisting that Verizon (NYSE:VZ) pay it $1 billion in licensing fees for 230 patents […]The post Market Morning: Huawei Strikes Back, 'No' on No No Deal, Ancient Chinese Stoners, Crowded CrowdStrike appeared first on Market Exclusive.
Colgate has found a way to make the toothpaste you rely on for a healthier smile a part of the solution for a healthier planet. Colgate has finalized the design of a first-of-its kind recyclable toothpaste tube that sets a new standard in the industry. The Association of Plastic Recyclers (APR) last week announced its recognition of the new tube – an essential step in bringing it to the public.
Is Colgate-Palmolive Company (NYSE:CL) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. […]
A look at the shareholders of Colgate-Palmolive Company (NYSE:CL) can tell us which group is most powerful. Generally...
After years of fluctuations, Procter & Gamble (NYSE:PG) finally broke out of its range in 2018. Procter & Gamble stock surged higher by more than 50% at its peak in a one-year period.Source: Mike Mozart via Flickr (Modified)This was the surge that took it out of the trading range it had maintained for six years. Still, after that move, many now wonder whether the stock will move higher or plateau.PG stock has long attracted income-oriented investors. Due to its long streak of dividend increases, PG has remained attractive to some even amid strategic pivots and competitive threats from emerging e-commerce players. However, valuations and headwinds coming from outside of the business could weigh on Procter & Gamble and the industry in general.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 6 Big Dividend Stocks to Buy as Yields Plunge PG Stock and StabilityLong-term holders should continue to benefit from a boring, but stable stock. Profit growth remains modest but also steady. Procter & Gamble also belongs to a short list of equities called "dividend aristocrats." These stocks have increased dividends annually for at least 25 years. In the case of PG stock, the streak has run for 62 years. I do not see any apparent reasons that will not continue.Further, PG remains vibrant even though its competitive moat consists of shelf space and name recognition. While consumers recognize Tide laundry detergent and Pampers diapers, they can choose worthy alternatives not produced by PG. Moreover, the rise of ecommerce threatens the importance of shelf space. I do not see sales falling off of a cliff, but that can present a headwind to company growth.Consequently, I see Procter & Gamble stock as a "don't buy." I would add that investors who bought 13 months ago have seen the PG stock price rise by as much as 55%. That group might want to consider selling. Procter & Gamble's New FocusTraders may have finally decided they like PG's strategic moves. Procter & Gamble remained rangebound for most of the decade as it restructured. In 2012, it sold Pringles to Kellogg (NYSE:K), exiting the food business. It has also exited other product lines in subsequent years.Despite these sales, acquisitions also continue. It also bought the consumer health division of Merck (NYSE:MRK) in 2018. Effective in July, it will employ what it calls a "simpler corporate structure" made up of six business units.Such strategic pivots relieve worries about a weak competitive moat. They should keep Procter & Gamble stock stable. Moreover, peers such as Kimberly-Clark (NYSE:KMB) and Colgate Palmolive (NYSE:CL) trade at similar multiples, offering little advantage over PG stock. Procter & Gamble Stock Is PriceyStill, for all of the income potential Procter & Gamble stock offers, it now appears overbought. The price-to-earnings (PE) ratio at around 24.5 exceeds its long-term averages. It's also a lot to pay for a company expected to grow earnings by 5.7% this year. That estimate could fall if tariff-related issues raise input and manufacturing costs.Moreover, while the dividend yield of 2.8% stands well above S&P 500 averages, PG has historically offered higher payouts.However, investors can find lower-cost dividend aristocrats for income. Equities such as AbbVie (NYSE:ABBV) and AT&T (NYSE:T) offer deeper competitive moats and higher dividend yields at much lower PE ratios.I expect that the rising payouts will attract many to Procter & Gamble. However, income-oriented investors can find both higher payouts and fewer competitive threats outside of the consumer defensive names. Final Thoughts on PG stockHigh multiples may hamper the near-term growth of not only Procter & Gamble but that of consumer defensive stocks in general. Despite strategic threats, PG should remain stable and continue to generate the cash flows that will fuel dividend growth for the foreseeable future.However, new buyers will have to pay close to 25 times earnings for an equity expecting profit growth in the mid-single-digits at best. In fairness, its most direct peers face a similar situation. Also, if one must buy a consumer defensive stock right now, I would recommend PG stock.Still, income-oriented investors seeking dividend aristocrats can find lower multiples and higher payouts outside of the consumer defensive sector. Rather than buying Procter & Gamble stock at these levels, investors should seek options with more profit potential.As of this writing, Will Healy is long ABBV stock. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Sell Impacted by the Mexican Tariffs * 6 Big Dividend Stocks to Buy as Yields Plunge * The 10 Biggest Announcements From Apple WWDC 2019 Compare Brokers The post Investors Aren't Likely to Clean up on Procter & Gamble Stock appeared first on InvestorPlace.
With a market capitalization of CA$215b, Cresco Labs Inc. (CNSX:CL) is a large-cap stock, which is considered by most...
Archer Daniels' (ADM) soft Carbohydrate Solutions segment is concerning. Nevertheless, the company's growth efforts such as the Readiness program are commendable.
Colgate (CL) exhibits strong surprise trend, owing to accelerated investments in brands, higher pricing and strong innovation along with expansion in new markets and channels.
The U.S. pet economy is projected to expand to a record $75.4 billion this year—even though state-of-the-art in doggy-doo retrieval remains the bag. How to play pet stocks.
Cannabis stocks turned lower Thursday, a day ahead of a key hearing by the U.S. Food and Drug Administration, seeking information and data on the substance and its ingredients with the aim of creating a regulatory framework for CBD.
As the markets get ready to finish a volatile month, I'd like to discuss the outlook of Procter & Gamble (NYSE:PG), the consumer-goods titan, whose shareholders have had a great year. Over the past 12 months, PG stock is up over 40%.Source: Mike Mozart via Flickr (Modified)Although I would not bet against Procter & Gamble stock in the long-term, I do not find PG stock a compelling buy at its current prices. I expect PG to undergo volatility and possibly weakness in June. Despite the many catalysts that make the shares an important part of a diversified portfolio, the company also faces several short-term risks. Here are the most important things that investors should know about Procter & Gamble stock. * 7 Stocks to Sell Amid an Escalating Trade War Procter & Gamble Has Strong BrandsMany consumer-staples companies have famous brands and robust fundamentals. I'view PG as one of the best consumer-staple names. Founded in 1837, the company is one of the largest manufacturers, distributors, and advertisers of consumer goods globally.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe company has five main segments: * Beauty, * Grooming, * Health Care, * Fabric & Home Care, * Baby, Feminine & Family Care.With its extensive product portfolio, it covers all the basic needs of consumers. On a given day, the average U.S. (and global) household is likely to use many of its brands, including Tide, Bounty, Downy, Pampers, Always, Charmin, Swiffer, Head & Shoulders, Crest, and Gilette.The strength of Procter & Gamble's brands is helping it achieve broad geographic reach and the benefits of large size in this competitive industry. PG Stock Benefits From Robust EarningsPG's fiscal third-quarter results, announced on Apr. 23 ,showed that its sales growth sped up, as its organic sales increased 5%. Chief Financial Officer Jon Moeller highlighted the quarter as the "third quarter in a row of very strong volume, sales, consumption and market share growth being driven by a strategy of superiority."Global annual revenue is over $66 billion and almost two dozen of its brands have annual sales of over $1 billion. Because these products have high margins, PG's return on capital employed (ROCE), a profitability ratio measuring how efficiently a company can generate profits, has been about 16%, which is viewed as healthy.The company has achieved those numbers through both organic growth and acquisitions. For example, the power of its brands enables Procter & Gamble to raise its prices without sacrificing a great deal of sales volume.Furthermore, over the past three years, Procter & Gamble has completed seven acquisitions. For example, in Dec. 2018, it finalized a $4.2 billion deal to purchase Germany-based Merck KGaA's Consumer Health business. PG said that the deal would help it expand its portfolio of consumer-healthcare products. The acquisition has increased PG's exposure to Asian and Latin American markets.Finally, Procter & Gamble's AA credit rating is possibly one of the best testaments of the company's fundamental strength. Procter & Gamble Stock Creates Shareholder ValueAnalysts have highlighted Procter & Gamble's improved margins, helped by cost-cutting across the company. Over the past few years, management has reshaped the company's portfolio to better serve changing consumer trends and spending habits.Dividends should play an important part in long-term investments. As a dividend aristocrat, Procter & Gamble stock is a favorite among income investors.PG's dividend yield is almost 2.9%. Its robust free cash flow will probably enable it to further increase its dividends in coming years. The company has raised its dividend every year since 1957. Over the past decade, PG's dividend has jumped over 60%. PG Stock May Not Be Immune to the U.S.-China Trade WarsAlthough it may not be one of the first stocks most investors think of when assessing the potential impact of the U.S.-China trade wars, Procter & Gamble stock is likely to be adversely affected by increased tariffs. In 2018, PG's management reported that tariff increases would raise the cost of making many of its products.PG relies on China for many parts and materials, such as pipes, tanks, and containers, that are used to manufacture and package its brands.As tariffs rise, PG would either have to increase its prices or absorb the costs. Increasing prices could hurt its sales, while absorbing higher costs would undermine its profitability. Either way, there would likely be downward pressure on PG stock.In April, even before trade-war tensions began intensifying, PG CEO David Taylor stressed that the company faced "a challenging competitive and macroeconomic environment." The rhetoric on tariffs won't ease the headwinds that Taylor described or the pressure they put on PG stock price. Is the Valuation of PG Stock Becoming Stretched?Wall Street has been voicing concerns about the rich valuation of PG stock. InvestorPlace columnist Luke Lango recently analyzed why investors may want to pay close attention to various metrics which indicate that the valuation of Procter & Gamble stock has become stretched.Furthermore rising commodity costs have been impacting the entire consumer-staples sector in the past few months. For example, prices for inputs like plastic, paper, and oil have been rising. Indeed in Oct. 2018, PG blamed rising costs for price increases it levied on many of its brands.Therefore, the owners of PG stock may want to assess the company's sales volumes when it reports its earnings in late July and October, in order to see if they are being adversely affected by the price hikes.If PG's volumes stay flat or fall, then more analysts may begin to find the current valuation levels of PG stock rather high, resulting in downgrades of PG stock. In 2018, a number of analysts downgraded Procter & Gamble stock due to rising commodity costs and price pressures that affected every segment of the company. Should Investors Buy PG Stock in June?At PG's current levels, I would not buy PG stock. Procter & Gamble stock has many long-term growth catalysts. However, PG is facing shorter-term risks which are likely to push down PG stock price and deflate its valuation.Furthermore, as a result of the recent impressive rise of PG stock over the past year, its short-term technical indicators have become somewhat overextended. Investors who pay attention to short-term oscillators should note that Procter & Gamble stock has become "overbought."So, in the next few weeks, PG stock may be negatively impacted by profit-taking. Investors may want to wait for a better time to buy PG stock, such as when the share price is around $90.Finally, investors who are thinking of buying PG may also want to pay attention to upcoming earnings releases by PG's peers, including Colgate-Palmolive (NYSE:CL), Kimberly Clark (NYSE:KMB), and Clorox (NYSE:CLX). Any weakness in their reports will likely put downward pressure on Procter & Gamble stock.As of this writing, Tezcan Gecgil did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Sell Amid an Escalating Trade War * 5 REITs to Buy While They're Dirt Cheap * The Only 3 Marijuana Stocks You Need to Own Compare Brokers The post Could the Tide Soon Turn for Procter & Gamble Stock? appeared first on InvestorPlace.
Colgate-Palmolive’s Prabha Parameswaran, President, Colgate-Europe, will present on Thursday, June 13, 2019 at the dbAccess Global Consumer Conference in Paris at 11:45 a.m. CET (5:45 a.m.
Brown-Forman's (BF.B) Q4 results are likely to benefit from robust brand portfolio. However, tariff-related costs are hurting underlying net sales and gross margin.